• Info
  • Insider Ownership

Insider Trading & Ownership of Charles Elliott Sigal

Location
Princeton, NJ
Summary
The estimated net worth of Charles Elliott Sigal is at least $928K dollars as of June 2, 2025. Charles Elliott Sigal is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $646K. Charles Elliott Sigal is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $282K.
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All Insider Reports
All Insider Reports

Notify me when Charles Elliott Sigal files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Charles Elliott Sigal

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. Director $646K May 8, 2025
VIR Vir Biotechnology, Inc. Director $282K May 30, 2025
ADAP Adaptimmune Therapeutics PLC Director Jul 3, 2023
SURF Surface Oncology, Inc. Director Sep 8, 2023

Insider Transactions Reported by Charles Elliott Sigal:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.